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Cancer touches all of our lives: we donate our money to help fight it; we
care for our friends and family members who have been afflicted by it; we may
ourselves be threatened by it. Thirty-three years after Richard Nixon launched
the war on cancer, this disorder, in all its multitudinous forms, still accounts
for more deaths each year in the United States than any cause except heart 
disease. It is a diagnosis that inevitably strikes fear.
Yet these are hopeful times for cancer research. Scientists once had only a
rudimentary understanding of the genetic and cellular mechanisms that allow
cancer to gain a foothold. The revolution in molecular biology has changed
that. Today, researchers doing basic science—exploring the inner workings of
our cells and our DNA—are finally uncovering the complexities of cancer. 
This new, detailed understanding is giving rise to new, improved strategies for
prevention, diagnosis, and treatment.
At Southern Illinois University’s Carbondale campus, we do not treat cancer
patients. The clinical departments of our School of Medicine are located at the
Springfield campus, which is building a new Cancer Institute for patient treat-
ment and research. But a number of cancer-related basic science projects at
Carbondale promise advances from designer drug therapy and delivery to
improved diagnostic tests. This issue’s special cover story describes a sampling
of this research.
Bringing those applications to fruition will eventually require collaboration
with clinical medicine researchers. The projects highlighted in these pages will
leave another legacy, though: what they uncover about normal and abnormal
cellular processes will aid the work of cancer scientists elsewhere. We are proud
of our researchers’ contribution and commitment to basic science that holds
promise to provide new tools in the fight against this dreaded disease.
John A. Koropchak
Vice Chancellor for Research and Graduate Dean
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The poster for Hilla
Medalia’s documentary
shows Ayat al-Akhras 
at left and Rachel Levy 
at right.
grant her interviews. She obtained
press credentials from the Israeli
government for herself and two 
fellow students in the College of
Mass Communication and Media
Arts: master’s student James Sal-
dana and undergraduate Chrissy
Mazzone. They traveled with her to
Israel to shoot footage over the
semester break. 
The result is “Daughters of
Abraham.” The title refers to the fact
that Abraham is the founding patri-
arch of both Judaism and Islam. 
Although the film includes some
historical background, it gives the
conflict a human face by concentrat-
ing on the personal lives of the girls
and on their parents’ reactions to
the bombing. Medalia directed, pro-
duced, and edited the 45-minute
documentary.
Political realities intruded on the
filming. Medalia had hoped to bring
the two sets of parents together, but
the Israeli government would not
allow Ayat’s parents to travel to
Jerusalem, and Rachel’s parents
would not enter the refugee camp.
Medalia knew it would not be safe
for her, either, in the camp. 
So Saldana and Mazzone shot
the footage there, and a Palestinian
friend, Adnan Tahah, conducted the
interview with the Palestinian par-
ents for her.
The interview with Rachel’s par-
ents was in English. But back home,
Medalia was faced with the thorny
problem of translating the lengthy
interview with Ayat’s parents before
she could edit that footage. “I can
understand a little Arabic, but that’s
about it,” she says. 
Fortunately, around this time she
met Imad Samarah, a Palestinian
doctoral student in management
information systems. He agreed to
Palestinian relations. 
Hilla Medalia, an Israeli citi-
zen working on a master’s
degree in mass communication
at SIUC, was deeply affected by
the news. She had already
intended to do her thesis film
on some angle of the Israeli-
Palestinian conflict. 
Medalia says she had been
looking for “a story of hope,
something that would break
misconceptions” and hold out
the hope of Israeli-Palestinian
co-existence. In media inter-
views, she listened carefully to
what the parents of Ayat and
Rachel had to say. Some of
their comments, she thought,
undercut the stereotype of
hatred that so many people
have of Israelis and Pales-
tinians. 
Medalia knew that she want-
ed her thesis project to give
voice to the feelings on both
sides of the conflict. She want-
ed to focus on individual experi-
ences rather than politics, and
she thought that viewers would
be able to relate to these two
young women and their fami-
lies. Through their story, she
says, she hoped to give U.S.
audiences “a feel of what life 
is like in the Middle East: one
side lives under a humiliating
military occupation, while the
other lives under the daily
threat of terrorism.”
In fall 2002, Medalia per-
suaded both sets of parents to
02
ResearchSurvey
TWO LIVES
As a home video, it’s shock-ing. A Palestinian teen-
ager faces the camera, a sui-
cide note in her hand. She reads
it rapidly, stridently, emphati-
cally. One senses an undercur-
rent of nervousness. Her state-
ment is short: in less than two
minutes, the clip is over.
On the same day she made
this video—March 29, 2002—
Ayat al-Akhras left her family’s
home in the Dheisheh refugee
camp, near Bethlehem in the
occupied West Bank, and trav-
eled the short distance to
Jerusalem. There, at the en-
trance to a grocery store, she
detonated the explosives belt
she was wearing, killing herself
and two Israelis. Media cover-
age later attributed her act to
her outrage over seeing a neigh-
bor shot to death by Israeli
troops.
One of the Israeli victims that
day was a girl who looked
almost like her twin. Rachel
Levy, who was shopping for her
family’s Sabbath meal, was 17.
Ayat was just 18. 
The news made the cover of
Newsweek. It also preoccupied
many Israeli and Palestinian
youngsters, the media reported.
These two girls, so similar in
many ways but divided by con-
flict, seemed to many people to
symbolize the tragedy of Israeli-
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graduate assistantship stipend
toward the film. Her parents
also helped out during filming,
allowing the crew to stay at
their house and providing
transportation.
Radio-television professor
Jan Thompson was “the force
behind everything,” Medalia
says. “When we went to Israel
to shoot, we had legal issues,
because Chrissy was only 19.
Jan took care of getting the
permissions we needed.
“She pushed me—gave me
deadlines that I thought were
impossible. So I’d go off and
just work [and get it done].
Some days I wanted to give
up—I was sick of sitting in the
editing room. But she was very
supportive.”
“Daughters of Abraham,”
which Medalia completed in
September 2003, has been
screened at SIUC and several
other universities.
Medalia graduates this
spring with her M.A. in profes-
sional media practice. She
plans to return to Israel after
gaining some job experience
in film or television. •
For more information: Hilla
Medalia, hillam15@siu.edu, or
c/o Jan Thompson, Dept. of
Radio-Television, (618) 536-
7555, janione@siu.edu.
—Marilyn Davis
do the translations—quite a time-
intensive commitment. 
“It took us over 50 hours,” 
says Medalia. “Translating Ayat’s
video was even more difficult
because she was quoting from
the Koran, and Koranic Arabic is
very different from contemporary
spoken Arabic.”
Both interviews reveal a gamut
of emotions, from hatred to empa-
thy. Both clearly express bitterness
about the years of bloodshed, not
just about this particular tragedy,
but both also communicate a
desire for peace. They hint at a
hope for understanding and co-
existence.
That certainly is Medalia’s hope.
It is one reason she chose music by
Sheva—a band made up of
Muslim, Jewish, and Christian
Israelis and Palestinians—to score
the documentary.
The filmmaking process, she
says, “was very hard. Not just
because of all the hours in the
editing room [agonizing over what
to cut]. The conflict is something I
live every day. Making the film
gave me a much deeper under-
standing of it.”
An early, 10-minute cut of the
documentary won Medalia a
Carole Fielding Student Grant, a
national award from the University
Film and Video Association. (She is
the first SIUC student so honored.)
This $2,000 grant helped fund the
work in progress. 
Medalia had some additional
financial support from Carbon-
dale’s Jewish community. Beyond
that, she spent several thousand
dollars from her own pocket—
charging expenses and getting
grocery money from her parents
so she could put much of her 
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Top: Chrissy Mazzone, a
senior in radio-television,
films on location in the
Dheisheh refugee camp in
the occupied West Bank.
Right: Hilla Medalia shoots
footage near Tel Aviv.
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SHUTTLE 
DIAGNOSTICS
America’s space program isbenefiting from the exper-
tise of an SIUC faculty member.
Tsuchin Philip Chu, an associ-
ate professor of mechanical
engineering and energy pro-
cesses, regularly works with
NASA scientists and engineers
to help solve complex problems.
His current project, funded
through a $30,000 collabora-
tive grant, involves developing a
software system for more pre-
cise detection of hydrogen leaks
in the nozzle of the space shut-
tle main engine.
The engine nozzle contains
more than 1,000 metal alloy
tubes, each about the diameter
of a straw, which run through
its length. They are attached to
a stainless steel jacket lining the
inner wall of the nozzle. 
Liquid hydrogen is pumped
through the tubes to cool the
nozzle while it is firing. The
hydrogen eventually flows into
the main combustion chamber,
where it is used as fuel. 
During flight, cracks or 
tiny holes can develop in the 
tubes from stress, temperature
changes, or corrosion, Chu
explains. Those defects allow
hydrogen to leak into the
spaces between the tubes and
the jacket.
Although no space shuttle
accidents have resulted from
such leakage, NASA knows that
it occurs. Inspection teams rou-
tinely detect leaks after a shut-
tle flight. The situation poses a
real danger: if cooling efficiency
were reduced too much during
flight, serious engine problems
could result—not to mention
the fact that leaked hydrogen
could explode.
NASA inspects and tests the
main engine nozzles after each
flight before they are sent to
Florida for installation on
another shuttle. Newly manu-
factured nozzles are checked
extensively as well. Chu’s soft-
ware will aid this inspection
process by enabling engineers
to zero in on leaks and repair
defective tubes.
The current procedure for
detecting the location of leaks
is inexact and “very tedious,”
Chu says. “They may have to
open up 20 or 30 tubes to
insert a [detection] scope, and
they still may not find the leak.”
Chu is part of NASA’s “non-
destructive evaluation” (NDE)
team, which develops better,
faster, noninvasive ways to
inspect shuttle parts. In this
case, leaks in the coolant tubes
can be pinpointed with thermogra-
phy—detecting and analyzing
slight temperature changes using
an infrared camera system and
image analysis software. Chu is
developing the software for a new
camera system that NASA is
implementing.
“We can detect the exact loca-
tion of the leak and can do it faster
and without cutting tubes,” he
says. “Once the detection system is
in place, you can save a lot of
money, because you can inspect a
large area at one time.”
“Right now [our] evaluation
techniques give us a general area,”
says NASA spokeswoman June
Malone. “Dr. Chu’s software is
going to give us more accuracy.
That will save a lot of time if you
can pinpoint exactly where a leak
is coming from.”
Chu has been traveling back
and forth to the Marshall Space
Flight Center in Huntsville, Ala., to
work on the new system. The pro-
ject will last through October 2004.
Chu’s collaboration with NASA
engineers dates to 1994, when he
participated in the NASA Faculty
Fellowship Program, a 10-week
summer research residency. An
expert on composite materials and
image analysis, Chu has held a
number of other NASA grants and
has worked at the Marshall Space
Flight Center almost every sum-
mer since 1997 on thermographic
inspection modeling and other
projects. •
For more information: Dr.
Tsuchin Chu, Dept. of Mechanical
Engineering and Energy Processes,
(618) 453-7003, tchu@siu.edu.
—Pete Rosenbery
ResearchSurvey
This launch photograph gives a good view of the nozzles
of the space shuttle’s three main engines. Tsuchin Chu’s new
software will better enable NASA engineers to pinpoint
hydrogen leaks in the nozzles. Photo by NASA.
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GREENER 
ALTERNATIVE?
G iven today’s environmen-tal and economic realities,
SIUC researchers think it’s time
to take a fresh look at propane
for use down on the farm.
“It’s readily available, the infra-
structure is already here, it burns
cleanly, and it’s an alternative fuel
source—it reduces our dependence
on oil from the Middle East,” says
Tony Harrison, an agricultural sys-
tems expert in SIUC’s College of
Agricultural Sciences.
“Is it better than the old reli-
able—diesel—that’s been around
for decades? Our job is to take it
out in the field and see. 
“We’re going to collect data in
our engine lab, then put it out
there and look at how it performs
under farm conditions so that we
can say if it’s all it’s made out to
be—and have the data to support
what we say.”
Harrison and his colleagues
Dennis Watson and Richard
Steffen will test the relative 
benefits of propane and diesel
fuel in a study involving an irri-
gation system. A $487,000 grant
from both the state and national
propane councils is underwriting
the two-year project.
“The small engine industry is
eagerly awaiting the results,” says
Bernard Sieracki, who serves on
the national council’s agriculture
advisory committee. “Nothing like
this kind of direct comparison has
ever been done before.”
The three researchers are set-
ting up a center-pivot irrigation
rig—one of those elevated, rolling
watering lines that circles around
a fixed point—on a 40-acre
field southwest of campus. 
In running the system’s
pump and pivot, automated
equipment will switch between
propane and diesel engines
during each watering period,
using an innovative hydraulic
system to allow each to oper-
ate at peak efficiency.
“This lets us compare
apples to apples,” Harrison
says. “If we test diesel one day
and propane the next, we’re
not running under the same
temperature and relative
humidity—and those affect
what the engine is doing.”
Electronic monitors will keep
track of emissions, fuel flow,
efficiency, and other data. In
the project’s final phase, the
researchers will set up wireless
transfer of information back to
campus so they can upload the
data on the project’s Web site. 
Site visitors will be able to
look at results from just one of
the power sources or compare
the two—on a particular day,
week, month, year, or over the
life of the entire project.
The project’s near-real-time
feature and its automated con-
trol and monitoring systems
should make it a desirable test
site for other kinds of power
sources, Harrison says. Accor-
ding to Sieracki, it is the only
test bed of its kind in the
United States. •
For more information: Dr.
Tony Harrison, Dept. of Plant,
Soil, and Agricultural Systems,
(618) 453-6985, tonyh@siu.edu.
—K. C. Jaehnig
Canola could make a comeback 
in the heartland’s fields.
“The biggest problem has been to identify 
winter-hardy varieties that would stand up consis-
tently to Midwestern conditions,” says Anthony
Young, professor emeritus in the College of
Agricultural Sciences.
“We have just now gotten to the point where we 
are consistently getting good survival rates for 10 or
12 varieties. Our mission over the next few years is 
to increase the acreage grown.”
Young heads the Midwest Regional Canola
Research Program, one of six such programs set up a
decade ago by the U.S. Canola Association to solve
regional production problems. His region consists of
19 states, with scientists from SIUC and four other 
universities conducting the research.
Demand is high for canola, whose oil is rich in 
heart-healthy omega-3 fatty acids, but growers in 
this country can’t begin to meet the need. The United 
States imports nearly all of the canola it uses.
Canola got a bad reputation in southern Illinois 
during the late ’80s and early ’90s, when farmers lost
virtually their entire crop several years running. That
won’t happen again, Young believes.
“We have taken about 400 lines developed out of the
Kansas State University breeding program and tested
them under local conditions,” he says. “We are also tak-
ing the best of these and making crosses with some of
our local varieties.” One of those crosses will soon be
released into national variety evaluation trials.
“With all that effort and the success we’ve had, we
are now ready to go back to the producers and say,
‘We will work with you to get the right varieties for 
your situation.’”
—K. C. Jaehnig
05
drive Cherokee Indians off
their land.
The Trail of Tears—actually
three overland routes and a
waterway—begins near Chatta-
nooga, Tenn., and ends in
Oklahoma. Rounded up like
cattle and stripped of their
property under the federal
Indian Removal Act of 1830,
thousands of Native Americans
were forced to march west on
the trail through winter storms.
Many died. Congress made the
trail a national historic area in
1987 to honor them.
Only a small piece of the
trail’s northern route runs
through Illinois, from Golconda
to a point just north of Cape
Girardeau.
“Unfortunately, a lot of it is
right under the existing high-
way—those parts are gone,”
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TRAIL OF TEARS
They called it the Trail ofTears because of the loss-
es suffered by the exiles whose
weary feet created it. 
Then it, too, was lost.
“If you know what you’re
looking for, you can see it—it’s
just so obvious—but unfortu-
nately, most people don’t know
what it is,” says John Burde, an
SIUC forestry professor.
Burde and graduate stu-
dents Karen Frailey and
Kevin Schraer have spent the
last few months tracking
down the Illinois leg of the
trail at the behest of the
National Park Service, which
is working to preserve and
develop the paths that 19th-
century soldiers once used to
Burde says, referring to
Illinois Highway 146. “A lot of
it has been plowed under for
agriculture, too. 
“But there are numerous
places not far from 146 where
the original road is quite obvi-
ous. We’ve pretty much identi-
fied the trail except for a piece
west of Jonesboro.”
After reviewing aerial pho-
tographs in fall 2003 to identify
segments of the trail, Burde
and Schraer began mapping it
on foot, using hand-held global
positioning system (GPS) equip-
ment that takes measurements
every five seconds. The equip-
ment translates radio signals
from satellites into geographic
information. The mapping had
to be done in the wintertime
because thick foliage can inter-
fere with the signals.
Fellow faculty member Andrew
Carver and his students in the
Forestry Department’s Geographic
Information System laboratory will
use the data to create detailed
maps showing trail segments,
topographic information, land use
patterns, and political boundaries.
Burde’s team also is digging
through archives and libraries,
hoping to root out old maps,
newspaper articles, letters, diary
references, and other materials
about the trail in southern Illinois.
Whatever they find will go into an
annotated bibliography, some-
thing that could be used not just
by researchers but by regular
folks who want to learn more
about the trail. 
“There’s a lot of interest down
here, a lot of community lore, and
a lot of people claim kinship to
the Cherokees because they
stayed some time in certain
areas—they didn’t just pass
through,” Burde says.
“We’ve already found some arti-
cles from the ‘20s and ‘30s. For
someone interested in looking
deeper, this would be a good point
to start.”
The research also could help
regional tourism development
efforts. For example, the Park
Service could use the material as
the foundation to build what
ResearchSurvey
Trail spotters: Karen
Frailey, a graduate student
in forestry, and Steven
Fadden, former site super-
intendent of Union County
Refuge, take a short break
from hiking the Trail of
Tears near Atwood Tower
in the Shawnee National
Forest. 
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Burde calls a tourist “interpretive
route”—a means for following the
trail and understanding what
happened there. 
As part of their report to the
Park Service, the team will iden-
tify potential interpretive/educa-
tional sites, recreational opportu-
nities along the trail, and ways to
preserve and develop existing
segments in partnership with
landowners. (For her master’s
thesis research, Frailey will iden-
tify and interview landowners to
see who might be willing to
allow hikers or interpretive signs
on the portions of the trail that
cross their land.)
“We’re behind other states in
this, probably because we have
the shortest number of miles—of
all the states that the trail goes
through, Illinois is the only one
without a museum or a cooper-
ating visitors’ center where peo-
ple could go to find out about
it,” Burde says. 
“But that doesn’t make Illi-
nois less important. Serious
winter events occurred here.
When the Cherokee got over
toward the river—in November
or December—the Mississippi
was iced over and they couldn’t
get across, so they had to set
up camps. A lot of people died.
“There’s a fairly large church
cemetery east of Anna that has
no headstones. The common
lore is that those are Cherokee
graves, but nobody knows. 
“Even with history, some things
get lost. That’s why the Park Ser-
vice has started this project.”  •
For more information: Dr. John
Burde, Dept. of Forestry, (618) 453-
7463, jburde@siu.edu.
—K. C. Jaehnig
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WEIGHT ON 
THEIR MINDS
K ids across America arestressing out about 
how much they weigh, worried
they’ll become super-sized like
many of the adults they see,
according to a new national
survey of 9- to 13-year-olds 
conducted by health educa-
tion experts at SIUC.
Results show that 59 per-
cent of the more than 1,100
youngsters surveyed have
already tried to lose weight;
54 percent worry about 
their weight; and 52 percent
agree there’s a problem with
kids being overweight today.
Health education professors
Stephen Brown and David
Birch conducted the survey on
behalf of KidsHealth - KidsPolls,
a consortium that gives chil-
dren a national platform to
share their views on health-
related issues that affect them.
On the upside, says Birch,
“children seem to be hearing
the many messages and warn-
ings being issued about obesity
and all the attendant problems
it can cause.” 
Brown says that this height-
ened awareness couldn’t come
at a better time. About a third
of all American kids are either
overweight or at risk of becom-
ing so—three times the percent-
age that were 20 years ago,
according to statistics gathered
by the Centers for Disease
Control and Prevention.
On the downside, however,
the survey uncovered some
excessive concern about body
image and achieving thinness.
Among other findings:
• Of the youngsters sur-
veyed, approximately 22 per-
cent reported being slightly or
very overweight, and 23 per-
cent said they weigh less than
they should.
• Fifty-six percent said
someone has spoken to them
individually about their weight. 
• While 55 percent of
youngsters said they are at
about the right weight, more
than half of that group—57 
percent—admitted they’ve tried
to shed a few pounds.
• A surprising 43 percent
of the kids who said they are
“slightly or very underweight”
also have tried to lose weight.
• Sixty-seven percent of
girls said they worry about their
weight, compared to 41 per-
cent of boys.
• Sixty percent reported
that it’s harder for overweight
kids to make friends.
• Sixty-nine percent believed
that healthy eating and exer-
cise are the best ways to control
weight; only 17 percent thought
dieting is more effective.
Responses to the survey
were gathered in November
2003 from children visiting nine
different health education cen-
ters around the country. The
youngsters live in large and
mid-size cities, suburbs, and
rural areas, and their ethnicities
mirror U.S. averages.
KidsPolls are a cooperative
project of the National Assoc-
iation of Health Education Cen-
ters, the Nemours Center for
Children’s Health Media (the
creators of KidsHealth.org), and
SIUC’s Department of Health
Education and Recreation. •
For complete survey find-
ings and methodology, visit
http://nahec.org/KidsPoll/.
—Paula Davenport
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ResearchSurvey
KUDOS
• History professor John Y.
Simon, executive director of the
Ulysses S. Grant Association, received
a 2004 Lincoln Prize for outstanding
achievement for the landmark 
The Papers of Ulysses S. Grant. This
scholarly edition of Grant’s corres-
pondence and other writings cur-
rently stands at 26 volumes.
Simon has worked on the project
since its inception in 1962. “It has been
an opportunity for me to spend time
with a spectacular figure in American
history,” he says. “Grant was a com-
plex character—an unmilitary sol-
dier, an unpolitical president and an
unliterary author.”
The Lincoln and Soldiers Institute
at Gettysburg College administers
the Lincoln Prizes.
• The National Science Foun-
dation’s prestigious Faculty Early
Career Development Award has
gone to two more assistant 
professors in SIUC’s Department 
of Chemistry and Biochemistry,
bringing its number of CAREER
Award holders to four. Yong Gao
won $465,000 for research on using
magnetic nanoparticles to recycle
reagents, catalysts, and other 
chemical compounds by extracting
impurities. Boyd Goodson won
$550,000 for research on using lasers and liquid crystal
solutions to enhance nuclear magnetic resonance (NMR)
studies of molecular structure and dynamics. 
• A highly competitive $30,000 media grant from
the National Endowment for the Humanities will enable
Tom Godell, associate director of SIUC’s Broadcasting
Service, and Jan Thompson, assistant professor of
radio-television, to research and write a treatment for a
two-hour documentary about influential 20th-century
conductor Serge Koussevitzky.
• SIUC’s 2003 Outstanding Dissertation award
went to Saikat Talapatra, who earned his Ph.D. in engi-
neering science. Working in the lab of physics professor
Aldo Migone, Talapatra did groundbreaking research on
the mechanisms by which gas atoms adsorb (bind) to
bundles of carbon nanotubes. These tiny tubes, whose
walls are only one atom thick, may someday be used in
energy systems to store hydrogen. 
Among other things, Talapatra determined the loca-
tion of adsorption sites, the surface area available for
adsorption, and the binding energy of various gases. His
lab experiments also showed that gas atoms adsorbed
to nanotubes behave like one-dimensional matter.
Milton Cole, a theoretical physicist at Pennsylvania State
University, has called the discovery “a landmark contri-
bution to science.”
• Anthropology master’s student Haagen Klaus won
the SIU Alumni Association’s 2 0 0 3  O u t s t a n d i n g
T h e s i s award for his excavation and analysis of a pre-
Incan metal and ceramic workshop and associated
cemetery on the north coast of Peru. By studying the
type, quality, and placement of grave goods at the
1,000-year-old site, as well as analyzing the human
remains for indicators of health and diet, Klaus made the
case that burial practices varied with the ethnicity and
status of the deceased. Izumi Shimada, the anthropol-
ogy professor with whom he worked, says that Klaus’s
work “constitutes an important contribution to the
rapidly expanding field of bioarchaeology.”
John Y. Simon
Boyd Goodson
Yong Gao
Haagen Klaus (at right) and a Peruvian crew member
excavate a pre-Incan grave. Photo by Izumi Shimada.
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dren have nine chances to
search for treats hidden under
cups; the better they remem-
ber where they searched previ-
ously, the more treats they can
find—and eat. 
Sessions will be videotaped
so that the researchers can
later record how many times
the children got out of their
seats, didn’t pay attention to
the task at hand, and so forth.
While children are taking
the hour-long battery in Espy’s
lab, their parents will meet
with members of Espy’s
research team, answering
questions about the kids’
actions and behavior at home
and at school. That will give
the team a fuller picture of
each child’s development.
them will undergo monitoring at
nine-month intervals from their
third birthdays until their sixth. A
smaller group of 40 to 50 chil-
dren will be added at each nine-
month interval, with regular
observation periods continuing
until their sixth birthdays.
“We wanted to have groups
coming in at staggered peri-
ods in order to separate how
much of the result is due to
development and how much is
due to [their] having done the
tasks over and over again,”
Espy explains.
Researchers will watch the
children perform three sets of
three tasks, each aimed at
measuring such functions as
memory and inhibition. In one
such task, for example, chil-
EXECUTIVE 
BEHAVIOR
How preschoolers developself-control is the focus of a
new five-year, $1.65 million study
at SIUC. 
“There are a number of disorders
[relating to self-control] that emerge
in the preschool period, attention
deficit disorder and autism being
two of the best known,” says
Kimberly Andrews Espy, associate
professor of family and community
medicine in the School of Medicine
and head of the research team 
conducting the study.
“Part of the reason the National
Institute of Mental Health funded
this project is that we know so little
about how [self-control] develops. 
If we can understand it in garden-
variety children, it will help us 
understand how these other chil-
dren get off the path.” 
Earlier work in Arizona with
toddlers exposed prenatally to
cocaine sparked Espy’s interest in
how children in general develop
self-control. The development that
takes place in children between
the ages of 3 and 6 is “dramatic,”
she notes.
“They move from being impul-
sive, in-the-moment kids who can’t
wait for anything to children who
can sit in a classroom, who can
get their needs met through
speaking, who can follow complex
directions. The scientific label for
this is ‘executive control,’ because
they, like executives, can manage
or guide their behavior purpose-
fully to achieve a goal.” 
Espy’s project ultimately will
involve some 400 youngsters from
all over southern Illinois. Half of
Neuropsychologist Paul Kauf-
mann, currently working on a
law degree at SIUC, helped
develop some of the task sets, a
host of research assistants are
conducting the sessions, and
University of Houston psycholo-
gist David Francis will assist with
data analysis at the end of the
three-year testing period. 
“Preschoolers are fun to work
with,” says Espy, who also heads
a five-year federal study on the
effects of prenatal nicotine expo-
sure on child development. 
“They’re spontaneous, they
try their best, and they say funny
things. It’s my favorite age.” •
For more information: Dr.
Kimberly Andrews Espy, (618)
453-1855, kespy@siumed.edu.
—K. C. Jaehnig
Asked by neuropsychologist Kimberly Espy to identify a shape by its color only if 
it’s not wearing a hat—and to ignore all shapes that have frowny faces—
four-year-old Mitchell Kaufmann has to stop and think.
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Researchers at SIUC are
tackling cancer at the 
molecular level. Some of
their work promises 
potential applications for
diagnosis and treatment; 
all of it adds to the pool of
knowledge that scientists
worldwide tap for insights
and answers. Wade on in 
as we tour cancer-related
projects on SIU’s 
Carbondale campus. 
Story by Marilyn Davis
Photographs by Jeff Garner, 
Russell Bailey, and Steve Buhman
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Cancer is a disorderly affair in which cells go out of control—
proliferating rapidly, refusing to die, overwhelming the body’s defenses, and eventually
growing into tumors. 
To fight the scourge of cancer, SIUC researchers in science, medicine, and agricul-
ture are working at the molecular level. Their research explores fundamental biological
processes; it goes by the heading of basic science. But some of these projects are leading
to possible applications—holding out the hope of improved diagnostic tests, new can-
cer therapies, and custom-designed materials for drug-delivery systems. 
Understanding each complex piece of the cancer puzzle takes years. Sometimes leads
that seem promising fizzle out. But negative results can be as important as positive ones,
because they help scientists refine their efforts. One way or another, by indirect and
sometimes surprising means, molecular-scale explorations in the lab eventually pay off
in the doctor’s clinic. The key to the war on cancer is understanding what can go wrong
with the intricate dance genes and proteins do, every day, to keep us alive—and how to
counter what goes wrong.
The right stuff
To do their job, genes must be expressed: translated into proteins. In a process called
transcription, the DNA in our genes acts as a template for the assembly of RNA mole-
cules. These RNA molecules shuttle off to special areas of the cell, where they in turn
serve as templates for the assembly of proteins from amino acids. Proteins drive the
business of the cell—and thus the business of life and death.
Genes must be expressed at the right times and to the right degree. If the wrong pro-
teins are being made at the wrong times, or in the wrong amounts, it opens the door
for all kinds of trouble, including cancer. Special proteins called transcription factors
govern gene activity, latching on to genes and controlling their expression. These factors
regulate protein levels in the cell by boosting, decreasing, or shutting off RNA tran-
scription.
SIUC physiology professors Jodi Huggenvik and Michael Collard, who study 
biological processes at the molecular level, have been teasing out the function of a 
transcription factor called DEAF-1, which plays a crucial role in embryo development
and neuron functioning. Their research strongly suggests that it also is connected with
cancer.
“Genes involved in embryonic development need to be on during a very specific time
and then usually need to be shut off—you don’t need them as an adult,” Collard says.
“DEAF-1 may function in shutting off these very powerful genes that drive develop-
ment. That can relate to cancer: if you have mutations in DEAF-1, then genes that
should be suppressed may get activated.”
DEAF-1 was first identified in 1996, in fruit flies. In 1998, Rhett Michelson, one of
Huggenvik’s doctoral students, stumbled across a similar transcription factor in monkey
cells. The SIUC research team soon identified the same factor in human and rat cells
and eventually determined that it was the mammalian version of DEAF-1. (Researchers
have since identified DEAF-1 in other species as well; it probably occurs in all animals.)
“We got very excited about this transcription factor,” Collard says, “because when we
 In these fluorescent cell images, a protein called DEAF-1 lights up red.
DEAF-1, which helps regulate DNA transcription, may function to suppress the
development of cancer. Photo by Philip Jensik, courtesy Michael Collard.
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grant to investigate whether DEAF-1 is a tumor
suppressor for Wilms’ tumors, a type of kidney
cancer in children.
One clue in that regard relates to gene inher-
itance and expression. We inherit two copies of
each chromosome and hence two copies of each
gene—one from our mother and one from our
father. Usually both copies of a gene are
expressed in the cell. Having this diversity is like
having an insurance policy: if one copy of the
gene becomes damaged, the cell has a backup.
In the case of a few genes, however, only the
maternal or only the paternal copy is expressed.
In gene-speak, the other copy is “silenced.”
These are called imprinted genes. 
Imprinting must serve some important phys-
iological purpose, because it comes at a high
price: no backup. The silenced copy of the gene
can’t take over if something goes wrong. And
cancer is a classic case of that. 
As tumor cells divide and multiply, they often
kick out “normal” copies of genes and duplicate
mutated or silenced copies. It’s significant, then,
that cells from Wilms’ tumors almost always
contain two paternal copies of the chromosome
region where DEAF-1 is found—and no mater-
nal copies. This chromosome region may host
an imprinted tumor suppressor gene that ends
up totally silenced in Wilms’ tumors because the
active copy is missing.
Huggenvik and Collard think that DEAF-1
is the most likely candidate for that tumor sup-
pressor gene. Certain complexities in the way it’s
transcribed suggest it is an imprinted gene, and
the chromosome region where it’s located—the
tip of the small arm of chromosome 11—con-
tains other imprinted genes. This region of
chromosome 11 seems to be mutated or
silenced in many human diseases, including
ovarian, lung, colon, breast, and prostate cancer.
DEAF-1 and prostate cancer
While Huggenvik and Collard continue to
test that hypothesis, a new National Cancer
Institute grant is allowing them to explore
DEAF-1’s role in prostate cancer. Co-investiga-
tors Kounosuke Watabe and Thomas Tarter,
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looked at its amino-acid structure, we
saw similarities with a number of other
transcription factors that are involved
in cancer.” When the researchers stud-
ied the chemical sequence of the DNA
that codes for the DEAF-1 protein,
their suspicions were reinforced. 
They also found evidence of a 
cancer connection in GenBank, a
worldwide database that archives DNA
sequences from around the world.
“People have submitted DNA se-
quences from cancer patients that cor-
respond to DEAF-1, but we find that
these sequences are often mutated,”
Huggenvik says.
Putting the brakes on cancer
DEAF-1 may be a tumor suppres-
sor—a gene that puts the brakes on
cancer. In cell experiments, Huggenvik
and Collard have found that the
DEAF-1 protein normally suppresses a
particular gene which is overexpressed
in lung cancer. The research team now
is deleting the DEAF-1 gene from spe-
cific tissues in mice to see if cancer
results.
If DEAF-1 is indeed a tumor sup-
pressor, mutations may destroy its anti-
cancer power. In fact, says Collard, “If
we mutate DEAF-1 [in test-tube
experiments], it seems to act like an
oncogene—a gene that drives cancer.”
Huggenvik and Collard’s early
research on DEAF-1 was funded by
the American Cancer Society and by
internal SIUC grants. In 2001 the
National Cancer Institute awarded the
two scientists a five-year, $1.17 million
CoverStory
Doctors might be
able to use DEAF-1
levels to more 
accurately diagnose
prostate cancer 
and gauge a
patient’s prognosis.
Jodi Huggenvik and Michael
Collard are investigating whether
a gene called DEAF-1 normally
acts to suppress tumor formation
and what may happen to “switch
off” that gene in certain cancers.
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faculty at the SIU School of Medicine in
Springfield, are establishing a tissue bank for
this study and helping to analyze protein expres-
sion in cells.
In pilot work, the team found that DEAF-1
levels were low or nonexistent in half of the
prostate tumor samples they analyzed. The
lower the levels, the less likely the patient was to
survive. 
If these early findings hold up in wider-scale
testing, doctors might soon be able to use 
DEAF-1 levels to more accurately diagnose
prostate cancer and gauge a patient’s prognosis—
information that could influence treatment.
Huggenvik and Collard also will try to 
determine what causes decreased levels of the
DEAF-1 protein in prostate cancer. It could be
due to gene mutations. But there is another 
possibility that holds more promise for patients. 
Genes are sometimes switched on or off
when they shouldn’t be because chemical units
called methyl groups have bound to them. “The
main way gene imprinting seems to be regulat-
ed is through DNA methylation,” says Collard.
In some types of cancer, in fact, it’s already
known that a tumor suppressor gene is being
silenced because of DNA methylation. 
“Right now, in clinical trials, [biomedical
researchers are] trying chemicals that might
interfere with methylation,” Collard adds.
“They’re hopeful that when genes get silenced
[in the disease process], they can turn them back
on, and vice versa.” If the DEAF-1 gene is being
silenced through methylation in prostate cancer,
perhaps some type of drug treatment could
reverse it.
Packing and unpacking
Also working at the gene level to tackle can-
cer is molecular biologist Blaine Bartholomew.
Although Bartholomew began his career by
studying transcription factors, recently he’s been
zeroing in on the cellular processes that make
transcription possible to begin with. 
Problems there, like problems with transcrip-
tion itself, can result in cancer. Bartholomew’s
research has been funded by the National
Institutes of Health for 14 consecutive
years, a remarkable record, and by the
American Cancer Society.
Most of us know the familiar illus-
tration of DNA as a long double helix
trailing down the page like a ribbon.
DNA is a double helix, all right, and it
is an incredibly long molecule. But in
real life it doesn’t exist in a leisurely,
relaxed state.
“If you lined up our DNA in one
straight line, it would be about one
meter long,” says Bartholomew. “In
order for it to fit into the nucleus of the
cell, it has to be compacted several
thousandfold.”
Small packaging proteins called his-
tones bind to the DNA and compact it.
The long strand of DNA winds around
thousands and thousands of these histones,
like little spools wrapped with one long
piece of thread. To condense things even
more, the whole assembly of histones is
twisted together tightly, resembling a 
beaded necklace that’s been knotted up.
This gnarly skein of DNA and proteins is
chromatin—the stuff that makes up our
chromosomes.
The cell’s compacting scheme works
wonderfully well, but it means that much
of the DNA is tucked deep inside the
chromatin package. “The problem is, the
cell has to gain access to DNA at certain
points in its life cycle,” Bartholomew says.
For genes to be expressed—transcribed
into RNA molecules and then translated
into proteins—the cell must somehow get
at the bits of DNA it needs to transcribe.
PERSPECTIVES • SPRING 2004
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This cross-section view of chromatin (above, left) shows DNA wrapping
around the outside of a histone—a protein “spool.” (The blue, green, yellow,
and red rods represent the four different proteins that make up the histone.)
Chromatin “remodeling” allows the cell to unspool DNA from a histone, free-
ing up a stretch of DNA so that it can be transcribed (see sequence at right).
Certain cancers are linked to problems with chromatin remodeling in cells.
Illustrations courtesy Blaine Bartholomew.
CoverStory
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On Target
Because chemotherapy takes such a heavy toll on the body, 
scientists have been working on ways to deliver drugs directly to
tumor sites, bypassing healthy organs. But they’d also like a way
to control the release of drugs from delivery devices. Better 
dosing control could decrease the side effects of toxic drugs and
make treatment more effective.
SIUC materials scientist Lori Vermeulen thinks a well-known
and safe material, clay, and a well-known and safe technology,
ultrasound, might be used to externally control the delivery of
drugs from implants or carrier medications.
An expert on designing and synthesizing layered materials
and polymers, Vermeulen was familiar with studies showing that
ultrasound could activate drug release from polymer implants. To
exploit ultrasound as a tool for controlling drug release, she
knew scientists would need to develop a broader materials base
for drug delivery. She thought that natural or synthetic clays
might fit the bill.
Clays, which are layered inorganic materials, can be induced
to host certain organic chemical compounds (“guests”) in the tiny
gaps between the layers. Ultrasound, she thought, might be used
to activate and control the release of guest drug compounds from
clay materials. 
“Things stick to clay. The idea is to stick the drug to it and
release the drug the way you want to,” she explains. “From a
chemist’s point of view, it’s easy to modify the structure of the host
to suit the drug.”
To test her hypothesis, Vermeulen’s lab team introduced 
several different guest compounds, including two containing 
biologically active molecules, into samples of a clay called mont-
morillonite. They suspended the clay samples in water and then
applied ultrasound. They found that they could affect how
rapidly and completely a guest compound was released from a
sample by varying the ultrasound frequency.
The team also got promising results with some synthetic clay-
like materials that Vermeulen designed. These materials, called
metal phosphonates, are layered like clay. But because they can
be designed to carry a wider range of guest compounds, includ-
ing proteins, they might prove to be a more versatile class of
materials for drug delivery.
The specific chemical and physical features of each clay com-
pound determine how these hybrid materials respond to ultra-
sound, Vermeulen says. For example, ultrasound breaks down
the particle size of the guest compound in some of the samples,
but not others. Such factors, along with environmental conditions
in the body, will determine the rate and degree of drug release.
But Vermeulen’s research suggests that it can be regulated. And
clays are biologically inert, making them a benign substance for
medical use.
Vermeulen’s proof-of-concept studies were funded by a grant
from the American Cancer Society. Master’s student Patricia
Calloway, now a chemist with Eli Lilly Co., did much of the lab
work and is writing her thesis on it.
Vermeulen plans to continue designing, synthesizing, and
analyzing various combinations of hosts and guests and testing
them with a range of ultrasound frequencies. Ben Baptist, a
chemistry major, has an undergraduate assistantship to help with
the research. Although their investigations are still at a very early
stage, Vermeulen hopes it will be possible to design materials
that can work in practice to deliver specific anticancer drugs.
Lori Vermeulen and chemistry major Ben Baptist.
When clay materials infused with a chemical compound
are suspended in water and subjected to ultrasound, the
compound is slowly released, turning the water yellow.
The longer the ultrasound exposure, the more of the
chemical that is released and the darker yellow the water
(see the sequence of tubes from left to right). The red liquid
is the original, undiluted compound.
Prime movers
Once again, as with transcription factors,
special proteins do the job. In this case, the
workhorses are so-called chromatin remodeling
complexes. “These are large assemblies of pro-
teins—protein machines, if you will—that reor-
ganize the chromatin package so the DNA is
accessible to the transcription machinery in the
cell,” Bartholomew says.
A remodeling complex works by glomming
onto the chromatin, pushing and prodding until
it uncovers the particular histone it wants. It
“unpackages” a stretch of DNA by pulling it
away from the histone (chromatin can expand
and contract much like a telephone cord
does). That allows transcription factors to get at
the DNA.
Transcription takes place as chemicals in the
cell bind along the stretch of DNA, self-assem-
bling into an RNA molecule. The remodeling
complex keeps “feeding out” the DNA until
transcription of the needed gene is done. The
completed RNA molecule then peels itself away,
leaves the nucleus, and heads for the cell’s pro-
tein-making factories. Mission accomplished.
“Ten years ago, it wasn’t even known that
these remodeling complexes existed,” says
Bartholomew. “Originally people thought tran-
scription factors were all it took to control gene
expression.” 
Now, he says, scientists know that remodel-
ing also is critical in keeping the cell functioning
smoothly. If the genes that code for chromatin
remodeling complexes are mutated, develop-
mental problems and embryo death can result.
So can cancer.
“If you take the proteins that are in remodel-
ing complexes and you mutate them in mice,
you find that the mice are much more predis-
posed to the formation of different cancers,”
Bartholomew says. 
“If you look at known cancers, you find that
in many cases genes involved in remodeling
complexes are mutated. For example, aggressive
pediatric cancers are highly associated with
defective chromatin remodeling complexes.”
SOUTHERN ILLINOIS UNIVERSITY CARBONDALE
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DNA in motion
To understand what goes wrong with
chromatin remodeling in cancer,
researchers first must understand how
remodeling normally works—in detail.
Bartholomew has pioneered a way to fol-
low the action.
Into DNA, his research team inserts
tiny molecular probes bearing radioac-
tive tags. The probes are made from
light-sensitive chemicals. When they’re
activated by a burst of light, a chemical
reaction takes place and each probe
transfers telltale radioactivity to any part
of the remodeling complex that’s touch-
ing the DNA in its vicinity. 
The researchers expose the chromatin
to a sequence of such light bursts, then
separate out the protein and DNA seg-
ments for analysis. By identifying the
radioactive bits, they can “map” the
action that took place in a particular
location. Doing this for multiple loca-
tions gives them a three-dimensional
view of how remodeling complexes and
DNA interact.
Bartholomew’s team is using this
labeling technique to study four chro-
matin remodeling complexes from yeast.
After they have a good handle on how
these complexes function normally,
they’ll make mutant versions of them to
better understand what can go wrong.
Why yeast, for heaven’s sake? Actually,
it’s a model organism for this kind of
work. 
“Yeast are easy to manipulate geneti-
cally,” says Bartholomew. “You can
delete genes readily and look at the
effects. And there’s a lot of similarity at
“If you look at
known cancers, 
you find that in
many cases 
genes involved in 
remodeling 
complexes are
mutated.”
Top:  Blaine Bartholomew
(standing) and lab technician Jim
Persinger look at protein analysis
results. Bottom:  Doctoral student
Bei Zhang prepares samples for
DNA analysis.
the molecular level between yeast and
humans.”
In fact, chromatin remodeling com-
plexes in yeast and humans are remark-
ably alike. Because they play such an
important role in the cell, they’ve
remained largely unchanged over hun-
dreds of millions of years.
By using the chemical probes men-
tioned earlier, Bartholomew’s lab
group has pinned down some details
about how a chromatin remodeling
complex can activate transcription. It
first “grabs” and loosens a short stretch
of DNA at the top of the histone, then
slides the DNA downward. “It creates
this unusual DNA loop that moves
[down] around the surface of the his-
tone like a wave,” Bartholomew says.
On camera, this might resemble an
elegant lasso trick. As DNA spools off
the other end of the histone, the his-
tone moves apart slightly from its near-
est neighbor, leaving an open length of
DNA between the two. 
Turn off, tune out
Each cell’s DNA contains the oper-
ating instructions for the entire body.
But a given cell only needs certain
genes switched on. A skin cell doesn’t
want genes that control kidney func-
tion to be active; it wants only the
instructions from skin-related genes,
and those only at the appropriate times.
As it happens, only one of the
remodeling complexes Bartholomew is
studying activates gene transcription.
The other three repress transcription by
condensing DNA. In short, some
remodeling complexes unpack DNA,
while others repack it and keep it put.
“Our data show that these two types
of complexes—those that activate and
those that repress—behave differently,”
Bartholomew says. “The one that acti-
vates transcription is much more dis-
ruptive to the chromatin. It does much more dra-
matic changing [of the DNA and histones]. 
“It’s also not nearly as abundant in the cell. The
other three complexes are 10 times as abundant.”
That isn’t so surprising, perhaps. “Usually
whatever gets done in a cell is working against the
pressures of repression,” Bartholomew notes.
“Most things are turned off most of the time. By
and large, most things that can be expressed are
not being expressed.”
Typos in our DNA
Cellular processes aren’t perfect, and mistakes
can be made during DNA transcription. Because
such genetic mutations often are the first step on
the road to cancer, understanding more about
them could help scientists find ways to prevent 
the disease. SIUC microbiologist Douglas Fix
studies how ultraviolet radiation damages DNA
and why a cell’s machinery for fixing that 
damage sometimes fails, causing mutations.
DNA is composed of two strands—the
famous double helix, which resembles a twisted
ladder. The “rungs” of the ladder consist of pairs
of four chemical bases represented by letters. T
always pairs with A to make a rung; C always
pairs with G. When it’s time for the cell to
reproduce, it must copy, or replicate, the exact
sequence of bases—millions of them in every
chromosome. Mutations are typos: mistakes in
the sequence.
Different types of molecules absorb different
wavelengths of light, and DNA happens to
absorb UV light. “As a result, the bases in DNA
can be excited by that energy and undergo
chemical rearrangements,” says Fix. UV light
can cause two neighboring bases in a DNA
strand to form an abnormal bond with each
other. The abnormality is called a lesion, and it
gums up the works when protein complexes in
the cell try to replicate or transcribe the DNA.
Fortunately, cells can repair most lesions by
stripping out the damaged bit of DNA and
resynthesizing it. These repair mechanisms are
typically “error-free,” meaning that they accu-
rately re-create the DNA. 
But when there’s a lot of damage, the cell’s
CoverStory
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When there’s a lot
of damage to DNA,
the cell’s repair
capacities falter.
Repair mechanisms
that are “error-
prone” kick in.
By looking at a DNA sample under
ultraviolet light, master’s student
Christian Coogan can isolate the DNA
fragment he needs to create a new
experimental strain of E. coli.
SOUTHERN ILLINOIS UNIVERSITY CARBONDALE
PERSPECTIVES • SPRING 2004
Damaged by the light
“For all the years that UV light has
been studied as a mutagen, it’s been very
difficult to make the kinds of correla-
tions between damage and mutation
that intuitively seem obvious,” Fix says.
“People have looked at damage distrib-
ution and compared that to mutation
frequency, and found little correlation,
in many cases.”
That may be because scientists have
overlooked a rare type of UV damage
where neighboring T and A bases be-
come bonded, he says. “Our pilot data
suggest it plays an important role in
mutagenesis even though it doesn’t
occur very often.” His grant project will
take a closer look at these T-A lesions
and their role in causing mutations. 
Fix’s lab also will investigate an unex-
pected type of mutation that they’ve
found sometimes results from C-T
lesions, a much more common type of
DNA damage. And they’ll investigate
another oddity they’ve discovered about
UV-related mutations.
When the cell replicates its DNA,
protein complexes must “zip open” the
two strands of the DNA molecule to
access them. For complicated reasons,
there are differences in the way the two
strands are copied. “We have prelimi-
nary data showing a fourfold difference
in the frequency of particular mutations
between the two strands,” says Fix. He
wants to know if this is a function of the
cell’s replication process or if UV dam-
age occurs more often on one strand
than the other—and if so, why.
Fix’s work, like Blaine Bartholomew’s,
is basic rather than applied science. 
“My research isn’t going to cure can-
cer,” Fix says, “but hopefully it will help
someone else understand more about the
process. Eventually the sum of knowl-
edge can lead to applications that are
very useful to all of us.”
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repair capacity falters. Repair mechanisms that
are “error-prone” kick in: they allow the cell 
to keep functioning, but at the price of muta-
tions. They sometimes substitute a C for a T, or
a G for an A.
Most mutations pose no problems. But some
can trigger a cascade of cellular reactions that lead
to cancer or other disorders.
By exposing cells to moderate doses of UV
radiation, Fix can cause enough DNA damage to
readily study DNA repair and mutations. For this
work he’s using a harmless laboratory strain of 
E. coli bacteria, a common choice for molecu-
lar biology experiments. 
“We know exactly what kinds of mutations
can occur in our strain of E. coli, and we know
the genetic sequence,” he says. “We also have
access to other strains with varying capacities for
DNA repair. We can analyze lots of samples very
quickly and collect lots of data. It’s much more
difficult and much more expensive to do that
with human cells, so we can cover more territory.
“Many of the mechanisms that repair DNA
are fundamentally the same in bacteria and
humans. By analyzing these fundamental
processes in E. coli, we hope to relate them to
things that happen in humans. We know that
UV radiation mutates human cells, and there’s
good evidence to suggest that the same types of
[lesions] that cause cancer in human cells cause
mutations in E. coli.”
Fix recently was awarded a National Cancer
Institute grant to correlate certain kinds of DNA
lesions with certain kinds of mutations and to
study their frequency. The grant, an Academic
Research Enhancement Award, will allow several
undergraduates to take part in the research.
By experimenting with different repair mecha-
nisms, Fix and his students can trace a specific
type of mutation back to the type of lesion that
caused the trouble. They also can determine how
often different types of UV-induced lesions occur
(some are a hundred times more common than
others) and roughly how often they tend to result
in mutations. A given type of lesion may trigger
mutations—may “foil” the cell’s repair capa-
city—way out of proportion to its incidence. 
Top: Master’s student Carisa
Anderson counts mutant bacterial
colonies in a petri dish. Bottom: Doug
Fix scans a DNA sequencing gel for
mutated base-pair sequences.
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The estrogen connection
Basic research can sometimes lead direct-
ly to applications, however. At SIUC, inter-
disciplinary work that began with funda-
mental research in chemistry has produced
what may be a useful new treatment for
prostate cancer. A group of scientists from
chemistry, physiology, animal science, and
food and nutrition are studying how 
estrogen-like compounds may contribute
to cancer—or be used to treat cancer.
An estrogen is any chemical compound
with estrogenic (feminizing) effects. The
estrogen produced in the human body is
estradiol, a steroid hormone. Women, of
course, need estradiol to lead healthy lives
and bear children. Men need it, too: for
example, men must convert testosterone to
estradiol in order to build bone tissue.
On the down side, some cancers, such as
some types of breast cancer, are fueled by
estradiol; they’re said to be estrogen-
responsive. And the estrogens in birth
control pills or hormone replacement
therapy carry risks for some women.
The SIUC group may have found a
way to dismantle this double-edged
sword—to separate useful estrogenic
effects from unwanted or harmful
effects. Like so many scientific
advances, this one was unplanned.
Cal Meyers, professor emeritus of
chemistry and director of the Meyers
Institute for Interdisciplinary Research
in Organic and Medicinal Chemistry,
picks up the story. “We were treating
estradiol with carbon tetrachloride—
just doing basic research on electron
transfer during fundamental chemical-
reaction studies,” he says. 
“When we did this we found that
the ring structure [characteristic of
steroids] opened up, so that the com-
pound was no longer a steroid. We had
the compound tested and found that it was very
estrogenic.”
By this simple chemical reaction, Meyers’ lab
had created a nonsteroidal, estrogen-like com-
pound. Its name is such a mouthful—bisdehy-
drodoisynolic acid—that they simply call it
BDDA. Meyers and several colleagues—chemist
Yuqing Hou, reproductive physiologist Todd
Winters, nutrition physiologist Bill Banz, mole-
cular biologist Stuart Adler, and biochemist
Walter Dandliker (all but the latter are with
SIUC)—have patented the use of BDDA as a
potential treatment for prostate cancer and other
medical conditions.
Estradiol and other estrogenic compounds
once were used to treat prostate cancer, because
they shrink prostate tissue and blunt testosterone
production. Unfortunately, they also shrink the
testes, causing impotence and sterility; they have
other feminizing side effects, such as breast
enlargement; and they promote blood clots. But
BDDA may change all that.
A plus for prostate cancer
BDDA, like many organic compounds, exists
in two forms: a “right-handed” structure and a
“left-handed” structure that are chemically iden-
tical mirror images of each other. They’re
referred to as the plus (+) and minus (-) struc-
tures, respectively. Meyers and Hou knew that
these two forms of BDDA might have different
effects on the body. So they convinced Winters,
Banz, and veterinarian Nancy Henry—all with
SIUC’s Dept. of Animal Science, Food and
Nutrition—to test them in lab animals. 
Meyers initially patented BDDA as a weight
loss agent, since the compound was found to
promote weight loss in female mice rather than
the weight gain associated with many estrogens.
But Winters, Banz, and Henry also discovered
another intriguing effect of BDDA. Testing it in
normal male rats, they found that both forms of
the compound shrank prostate tissue—but that
the right-handed version, (+)-BDDA, did it
with almost no shrinking of the testes or other
feminizing side effects. 
This finding raised the intriguing possibility
Chemist Cal Meyers holds a model of the BDDA molecule, a potential anti-
cancer agent. Behind him, from left: chemist Yuqing Hou; physiologist Stuart
Adler; Joseph Stringer, a junior in chemistry; and Songwen Xie and Aaron
McLean, doctoral students in chemistry. These researchers have worked to
synthesize and modify BDDA and related compounds and to understand how
they function in the body.
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that (+)-BDDA might be used to treat prostate
enlargement or even prostate cancer. The team
went on to determine that oral preparations of
this compound, not just injected preparations,
were effective—a key selling point for eventual
studies in humans. 
Working with cell cultures, Henry found that
(+)-BDDA inhibits the growth of human
prostate cancer cells. “The effect is statistically
significant and consistent,” she says.
At that point the team asked Dennis Lubahn,
a physiologist at the University of Missouri,
Columbia, to test (+)-BDDA on a special strain
of transgenic mice that spontaneously develop
prostate cancer. If the compound keeps the can-
cer in check in these animals, the SIUC team
hopes that a pharmaceutical company will step
in to fund stage-1 clinical trials in humans.
Designer drugs
The work with BDDA opens up the possibili-
ty of making other “designer” estrogens.
Songwen Xie, a doctoral student working with
Meyers, has developed “a battery of compounds
that may be as good as or better than BDDA,”
Winters says. 
Designer estrogens might be developed to
treat some types of breast or uterine cancer, or
to fine-tune birth control or hormone replace-
ment therapy so these drugs have fewer unde-
sirable side effects.
“It looks like the whole package [of estro-
genic effects] is separable,” says Stuart Adler,
an associate professor of physiology who also
is part of the team. “We may be able to pick
and choose the effects we want.” 
Hormones like estradiol bind to proteins
called receptors. In the case of estradiol, the
receptors are located in the nucleus of the cell.
After binding takes place, the hormone/recep-
tor complex interacts with various proteins in
the nucleus to change gene expression and
produce hormonal effects.
“We used to think of this [binding] with recep-
tors as being like a lock and key,” says Adler. “If
they were the right shape, compounds would fit
into the receptor and open the lock. But we now
know there are subtle shape differences
among compounds that can activate the
estrogen receptor.” 
As it turns out, the “lock” can be
opened to varying degrees. Consequently,
some compounds that fit the receptor
rather poorly—that open it just part-
way—can still produce substantial
estrogenic effects. 
Just as surprising, some compounds
produce estrogenic effects in some tis-
sues and anti-estrogenic effects in other
tissues. For example, the cancer drug
Tamoxifen normally blocks estradiol’s
effects in the breast, but it acts like estra-
diol on the uterus. (Thus breast cancer
patients on Tamoxifen must be closely
monitored for uterine cancer.)
These selective effects gave rise to a
new term: SERM, for selective estrogen
receptor modulator. Tamoxifen was the
first known SERM compound; Meyers
and Adler think that BDDA may be
another. BDDA “hardly binds at all” to
the estradiol receptor, says Meyers—yet
it has strong estrogenic effects. And like
Tamoxifen, it produces only some of
estradiol’s effects.
This selectivity, which holds so much
promise for medical applications, poses
difficulties for cancer-related environ-
mental research. Many industrial chem-
icals that are widespread in the environ-
ment can interact with estrogen recep-
tors. Scientists want to know what
potential health risks, including cancer
risks, are posed by these so-called “envi-
ronmental estrogens.” 
Because environmental estrogens
may act as SERMs, toxicology testing of
these compounds must be more com-
prehensive than scientists might have
anticipated, Adler says. For example,
you can’t just look at effects in one type
of tissue, because a SERM can be
benign in some tissues but carcinogenic
in others. Adler thinks that BDDA
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offers “a perfect model system” for exploring
some of these complexities.
Oddly enough, phytoestrogens—estro-
genic compounds produced by plants—
may provide some defense against environ-
mental estrogens. Winters, Banz, and
Henry have studied the physiological effects
of soy phytoestrogens (there are several dif-
ferent types of these compounds), including
effects on reproductive tissue.
The promise of soy
Where cancer is concerned, they say, the
soy story is promising, but complicated.
Estrogenic soy compounds have different
effects in different types of tissues and can
actually make matters worse in the case of
certain cancers. For example, some labs
have found evidence that low doses of
genistein, one of the soy phytoestrogens,
can stimulate some types of breast cancer
cells.
On the other hand, soy seems to have
protective effects if consumed early on and
regularly. People living in Asia, where
high-soy diets are common, have much
lower rates of prostate and breast cancer
than U.S. residents do. By keeping some of
the body’s estrogen receptors occupied, soy
phytoestrogens may be able to keep envi-
ronmental estrogens from binding and
having pernicious effects.
Henry notes that many animal studies
indicate that soy offers protection against
the risk of cancer from environmental
estrogens. This protective effect isn’t due
One type of 
“designer” estrogen
patented by SIUC
researchers may be
useful against
prostate cancer.
CoverStory
solely to phytoestrogens, however; soy protein
plays a role as well. Consumers should get their
soy by eating foods like tofu, says Banz, not by
taking supplements.
In a major three-year project, Winters, Banz,
Henry, and Adler also are investigating the syn-
ergistic effects of soy phytoestrogens and certain
vitamins on prostate cancer. The study is sup-
ported by a $429,148 grant through the Illinois
Attorney General’s Office from a vitamin
antitrust settlement fund. “Other scientists have
looked at phytoestrogens and vitamins separate-
ly,” says Henry, “but putting them together is
where we’re getting great results.”
The researchers fed one group of normal
male rats a soy-free diet, a second group a low-
phytoestrogen soy diet, and a third group a
high-phytoestrogen soy diet. Within those three
groups, some of the rats received a high dose of
vitamin A, some received vitamin D, some
received vitamin E, and some received no extra
vitamins. After eight weeks, the team found that
the diet combining vitamin E with a high level
of soy phytoestrogens had a pronounced effect
in shrinking the size of the prostate.
Henry then tested combinations of vitamins
and various soy phytoestrogens on human
prostate cancer cells. “Vitamins E and D in com-
bination with each other and with soy phyto-
estrogens basically stop growth of prostate cancer
cells [in culture],” she says. “We’re excited about
these results.” 
Of the phytoestrogens, genistein seems to
have the most significant effects. The team
now plans to implant human prostate cancer
cells into immunosuppressed mice and see if
the vitamin/soy combinations can hold the
cancer cells in check or kill them. 
Meanwhile, Adler is studying what happens
when soy phytoestrogens bind to estrogen recep-
tors. Scientists have found that two protein fam-
ilies in the nucleus act as modulators for estro-
genic compounds. One family helps the com-
pounds activate estrogen receptors; the other
family has the opposite effect. These critical mod-
ulators vary across cell types, which may account
for some of the selective effects SERMs have.
Ginseng and Cancer: A Follow-Up
In spring 2001, Perspectives visited the lab of physiologist Laura Murphy to
report on cancer research involving ginseng. Three years later, that work still
looks promising.
Murphy and her students had found that a water extract of American gin-
seng slowed down the growth of human breast and prostate cancer cells in
culture. They also had discovered that female mice injected with human
breast cancer cells develop much smaller tumors if their drinking water is
laced with ginseng. (Because these mice are immunosuppressed, they can’t
fight off the cancer themselves.)
Since then, Murphy’s lab has tested the effects of ginseng on breast cancer
cells resistant to chemotherapy drugs, including hormone therapies like
Tamoxifen. “Cancer in general is pretty bad about developing resistance [to
drug therapy],” says Murphy. “Cancer cells develop resistance to different
drugs through different means, but regardless of the mechanism, we’re able
to inhibit proliferation of these cells with ginseng.”
A $150,000 grant from the Penny Severns Breast and Cervical Cancer
Fund through the Illinois Department of Public Health is funding these studies.
And a new, $300,000 National Cancer Institute grant will allow Murphy to
study the effect on cancer cell cultures of ginseng co-administered with various
chemotherapy drugs. In early experiments, she has found “much greater inhi-
bition of cell growth” with the combination than with either compound alone.
She’s already begun following up those findings with animal studies. 
“We’ve given subtherapeutic doses of ginseng and of cancer drugs to
immunosuppressed mice that we inoculated with human breast cancer cells,”
she says. “Individually, these are doses at which we would not expect to see
a therapeutic response. But when you give them together, it seems to prevent
the cancer from growing.”
These animal studies are treating cancer at a very early stage, although
the cells themselves are from advanced metastatic human cancers. “We want
to look at full-blown cancer in the near future,” Murphy says. The goal of the
NCI grant is to lay the groundwork for studies in humans.
Some retrospective research studies, most done in Korea, indicate that peo-
ple who consume a lot of ginseng as part of their normal diet have a lower
incidence of cancer. Such dietary consumption appears to be safe. But
Murphy cautions against people self-dosing with supplements, which
may be adulterated or ineffective and can interfere with other drugs.
There are some 20-25 active compounds in ginseng.
Murphy would like to test all of them, determine which ones
maximally inhibit cancer cell growth, and combine them to
get “a potent anti-cancer cocktail.”
Will ginseng fulfill its promise for human cancer
patients? Much work remains before the answer is
known. Murphy is optimistic, however. 
“This is some really exciting stuff,” she says.
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Top: Todd Winters shows the different
effects that the two forms of BDDA have on
prostate and testis tissue in rats. Middle:
Nancy Henry (right) and Monica Zaworski,
a senior in animal science, have tested
BDDA, soy phytoestrogens, and vitamins
on human cancer cells.  Bottom: Bill
Banz (left) and his students (here, under-
graduate Ben Wooley) have tested BDDA
and phytoestrogens in lab animals.
Adler has shown that at least one soy phyto-
estrogen, genistein, can change the levels of the
modulators, making the cell less responsive to it
and to other environmental estrogens. By doing
so, genistein is telling the body, in effect, “We’re
not really estradiol, even though we look simi-
lar.” This adaptation may prevent health prob-
lems by neutralizing what would otherwise
amount to an increase in estrogen load.
With funding from the National Institutes of
Health, Adler is investigating the molecular
mechanisms and gene sequences that allow genis-
tein and other SERMs to influence modulator
levels. “If we can understand the different classes
of modulators, we might be able to make cancer
cells more responsive to therapy,” he says. 
Returning to the designer drug concept, he
raises the possibility of tailoring cancer therapy by
combining compounds that block certain effects
with compounds that promote other effects. 
“It’s not just a pipe dream to think that we can
do this,” he says. “The goal is to go from the
bench to the bedside. It’s still a big step to get to
clinical trials, but ultimately we want to be help-
ing people.”
Adds Meyers, “That’s why interdisciplinary
research is so important.
“We’ve got work to do.” •
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FeatureStory
The Irish who came by the millions to U.S. cities in the 1800s faced pre–udices that dismissed them as drinkers, brawlers, and illiterate 
liars. They were called uncivilized
and subhuman. Their religion (most were
Catholic) was often viewed with hostility.
They endured grinding poverty in inner-
city tenements, did backbreaking labor,
and encountered discrimination in jobs
and housing. 
“They were pioneers of the American
ghetto,” says Charles Fanning, a professor
of English and history at SIUC.
From this rough beginning came count-
less success stories and one of this nation’s
great ethnic heritages. (More than 40
million Americans today claim some
Irish ancestry.) From it also came a dis-
tinctive literary voice that tells us a great
deal about our shared history.
It’s thanks to Fanning—widely seen
by literature and history scholars as the
dean of Irish-American studies—that so
much is known about this voice. Until
he began his research, in the early 1970s,
most Irish-American writing prior to
1900 had been forgotten, overlooked on
library shelves and hidden away in dusty
newspaper and periodical archives.
Focusing mostly on fiction,
Fanning has excavated this literature
and reintroduced it to the world. Three of his
books have won national awards, and this year
SIUC has recognized his achievement with the
Outstanding Scholar award.
Fanning, who is half Irish, grew up in the “very
Irish” small town of Norwood, Mass., now a sub-
urb of Boston. (He remembers, as a child, hear-
ing Irish spoken on the streets by immigrants
from Galway, though he never learned the lan-
guage himself.) He went to Harvard for his bach-
elor’s degree and a master of arts in teaching, then
earned an interdisciplinary doctorate in American
civilization from the University of Pennsylvania,
focusing on literature, history, and art.
For his dissertation he wanted to treat an
Irish-American topic, in part to learn more
by Marilyn Davis
PERSPECTIVES • FALL 2000SPRING 2004
22
F
e
a
t
u
r
e
S
t
o
r
y
SOUTHERN ILLINOIS UNIVERSITY CARBONDALE
PERSPECTIVES • SPRING 2004
19th century. Searching out other lost
and neglected writers, he combed the
card catalogs and shelves of the nation’s
best archives, including Harvard’s
Widener Library, the Library of
Congress, the New York Public Library,
and the Newberry Library in Chicago. 
To fund his work, he won fellow-
ships and grants from a veritable
“Who’s Who” of agencies and organi-
zations that support humanities
research: the National Endowment for
the Humanities, the Rockefeller
Foundation, the American Council of
Learned Societies, the American
Antiquarian Society, and others.
Fanning’s discoveries illustrate the
profound interconnectedness of history,
culture, and literature. Before the
1840s, Irish immigrants came to
America by choice. Although they faced
prejudice, they were well educated and
well adjusted to life in the States. 
“That early stage of writing has lots 
of satire and parody,” says Fanning.
“The early generations of immigrants
were confident enough to laugh at them-
selves, at the view that other Americans
held of them, and at America.”
But this sophisticated comic fiction
did not last. As Fanning writes, “All
such laughter stopped” with the Great
Hunger—the years of famine in Ireland
resulting from the potato blights of
1845. More than a million people died;
some million and a half emigrated to
the United States between 1845 and
1855. These “involuntary” rural immi-
grants came to America’s cities to escape
starvation, only to suffer widespread
poverty and disease.
Earlier Irish-Americans had written
for the general public, but “Famine
Generation” writers wrote for other
immigrants. They produced “rags-to-
riches” stories; romantic novels thick
with nostalgia for the home country;
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about his own heritage. “I’ve always been inter-
ested in how literature helps us clarify history,
and vice versa,” he says. He found an ideal 
subject in a Chicago bar.
Mr. Dooley, a fictional Irish-American bar-
tender with humorous opinions on politics and
life, was the creation of Irish-American journal-
ist Finley Peter Dunne. In the late 1890s Dunne
gained national fame with his syndicated news-
paper columns written in Dooley’s persona. But
Dunne’s pre-syndication columns, published in
the Chicago Evening Post, were the ones that
intrigued Fanning.
In these earlier, grittier columns, full of social
commentary and political satire, Mr. Dooley
told the stories of his Irish neighbors on
Chicago’s near South Side. Fanning’s digging
uncovered 300 of these pieces that had never
been collected. Together, he says, they give “as
full a picture as you’re ever going to get of what
it was like to be a working-class Irish immigrant
in an American city in the 19th century.”
The columns became the focus of his doctor-
al dissertation and, in 1978, of his first book.
Finley Peter Dunne and Mr. Dooley: The Chicago
Years netted Fanning the 1979 Frederick
Jackson Turner Award from the Organization of
American Historians. In 1987, he grouped
many of the columns by theme and republished
them with commentary as Mr. Dooley and the
Chicago Irish: The Autobiography of a Nineteenth-
Century Ethnic Group.
“Dunne is the first Irish-American voice of
genius,” says Fanning. “He thinks enough of
these people—factory workers, laborers—to
dignify their lives and to turn them into real 
literature. And he does it in an Irish brogue.”
When other 19th-century writers wrote 
dialogue in brogue, it was to mock the Irish.
Dunne turns that notion on its head, Fanning
explains: “He does for the Irish-American voice
what Mark Twain does when he lets Huck Finn
tell his own story [in his own dialect]: he legit-
imizes it. The best of Dunne’s pieces are elo-
quent and beautiful.”
In the 1980s, Fanning broadened his research
to the entirety of Irish-American literature in the
and, above all, moralizing books showing
readers how to get along in America and
warning them not to be tempted away
from Catholicism.
Most of this fiction had unlikely plots
and sentimentalized characters, but it was
realistic in one respect: setting. “This litera-
ture tells you what the inside of a tenement
flat looked like and how people lived day to
day,” says Fanning. “Even in the didactic
stuff you get a vivid depiction of daily life
and working conditions. You also get plenty
of illustrations of anti-Catholic prejudice”
faced by Irish-Americans. Literature, he
says, makes these issues “concrete.”
Fanning collected many of the shorter
pieces he “reclaimed” in The Exiles of 
Erin: Nineteenth-Century Irish-American
Fiction (1987), which won the American
Book Award from the Before Columbus
Foundation for outstanding contribution
to American literature.
As the 1800s came to a close, writers
treating Irish-American themes, like
Dunne, began to publish realistic fiction
once again geared to general readers. But
the Irish-American voice fell silent in the
early 1900s, Fanning discovered. Thanks
to anti-immigrant sentiment and the tur-
moil of World War I (which put anti-
British Irish nationalists in America in an
awkward political position), not many
writers wanted to call attention to their
ethnicity. After legislation in the early
1920s that restricted immigration, there
were few Irish newcomers. And as the
Irish-American middle class grew, it
focused on assimilation. 
Fanning calls this a period of “cultural
amnesia.” The next great writer to treat
Irish-American themes, James T. Farrell,
essentially had to reinvent Irish-American
literature from scratch in the 1930s, he says.
Farrell began his career with the Studs
Lonigan trilogy, his most famous novels,
and followed up with dozens of other
books, all centered in a mostly Irish 
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exchanges with the National University of
Ireland, Galway.
Fanning, who has written, co-written, or
edited 12 books, has two more irons in the
fire right now. One is a wide-ranging memoir
about his own upbringing and ancestors, which
he is enjoying greatly. 
“It’s very freeing,” he says of this type of 
writing, which will look at history through the
prism of his family and home town.
He’s also writing and gathering illustrations
for a book on Irish-American culture during the
Great Depression. “I’m discovering that there
was a tremendous flowering of Irish-American
art in the 1930s,” he says. “I’m looking at 
writers, artists, radio-comedy people, comic-
strip creators. It’s kind of a renaissance, and no
one has really put it all together.”
Recent years have seen a resurgence of inter-
est in Irish music and dance. Now the work
done by Fanning and the students following his
lead is opening other new avenues to explore the
vibrant Irish-American past. •
For more information, contact Dr. Charles Fanning,
Dept. of English, celtic42@siu.edu.
working- and middle-class enclave on
Chicago’s South Side in the first half of the
20th century. “Farrell does for the South
Side of Chicago what William Faulkner
does for that little county in Mississippi
and what [James] Joyce does for Dublin,”
says Fanning. “He makes it universal.”
Fanning collected some of Farrell’s
shorter pieces in Chicago Stories of James T.
Farrell and is organizing a celebration of
his work at the Newberry Library this year,
the 100th anniversary of his birth. Since
Studs Lonigan, he says, Irish-American fic-
tion has blossomed, and it still centers on
urban life. Two of Fanning’s favorite con-
temporary writers are William Kennedy,
whose best-known novel, Ironweed, is one
of a cycle of Irish-themed novels set in
Albany, and Alice McDermott, whose
novel Charming Billy, set in New York City,
won the National Book Award in 1998.
The common thread in 20th-century
Irish-American literature, Fanning says, is
“the idea of community fostered by a 
specific place. Irish-American writers have
[their universe] in the city neighbor-
hood—it’s enough of a canvas for them
to do their work.”
Fanning’s own masterwork is The
Irish Voice in America, which covers the
entire scope of Irish-American fiction.
Published in 1990, with an expanded
second edition in 1999, it won the
American Conference for Irish Studies’
Prize for Literary Criticism, and histo-
rian Lawrence McCaffrey says it estab-
lished Fanning as “the leading Irish-
American studies scholar.”
Fanning came to SIUC in 1993 to
build an interdisciplinary program in
Irish and Irish immigration studies
drawing on strengths in several depart-
ments and on the top-notch Irish 
literature holdings at Morris Library’s
Special Collections. With the help 
of a $240,000 grant he received in
1995 from the U.S. Department of
Education, the new program has host-
ed international conferences, devel-
oped new courses and online resources
(see www.siu.edu/~ireland), and fund-
ed scores of faculty and student
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“T his literature 
tells you what 
the inside of a 
tenement flat
looked like and
how people lived 
day to day.”
—Charles Fanning
SightLines
It was nearly a sweep: graduate and
undergraduate students of SIUC documentary
photographer Dan Overturf dominated two of
the three college/university award categories in
the Photo Imaging Education Association’s
2004 photography competition. 
For the second year in a row, the grand prize
in the portfolio category went to M.F.A. student
Josh Sanseri, whose graduate thesis show will
focus on owners of small businesses. M.F.A. stu-
dent Polly Chandler took first prize in this cate-
gory, and Nicole Isaacson took third. Grand
prize in the single-image category went to
Andrea Behrends; Ann Dodge took second
prize; and Ed Frey III took third. 
SIUC photography students have landed a
grand prize in the PIEA competition for seven
consecutive years—ever since they began enter-
ing. Prize-winning photographs are exhibited at
the PIEA’s annual convention and in venues
around the country and are posted online (see
www.piapma.org).
—Marilyn Davis
Peerless Portraiture
“Marge,” by Josh Sanseri. 2003.
“Herin,” by Polly Chandler. 2003.
“Ross,” by Andrea Behrends. 2003.
“Buddy,” by Ann Dodge. 2003.“Dad,” by Nicole Isaacson. 2003.
